#1 Clinical Trials Search in Europe

Tamsulosin Hydrochloride

Tamsulosin Hydrochloride, commonly known by its brand name Flomax, is a medication that has been extensively studied in clinical trials for its effectiveness in treating Benign Prostatic Hyperplasia (BPH) and associated lower urinary tract symptoms (LUTS). These trials have explored various aspects of the drug, including its efficacy, safety, and bioequivalence of different formulations. The studies have involved different dosages and compared Tamsulosin with other treatments, providing valuable insights into its use for patients with BPH.

Table of Contents

What is Tamsulosin Hydrochloride?

Tamsulosin Hydrochloride is a medication primarily used to treat urinary symptoms associated with an enlarged prostate, a condition known as benign prostatic hyperplasia (BPH). It belongs to a class of drugs called alpha-blockers[1]. Tamsulosin is known by various brand names, including Flomax®, Harnal-D, and GL2702 GLARS-NF1[2][1].

Conditions Treated by Tamsulosin

Tamsulosin is primarily used to treat:

  • Benign Prostatic Hyperplasia (BPH): This is a non-cancerous enlargement of the prostate gland that can cause urinary symptoms[1].
  • Lower Urinary Tract Symptoms (LUTS): These are urinary problems often associated with BPH, such as difficulty starting urination, weak urine stream, and frequent urination[1].
  • Urinary Retention: In some cases, Tamsulosin is used to prevent urinary retention (inability to empty the bladder) after certain surgical procedures[3].
  • Kidney Stones: Tamsulosin may be used as part of medical expulsive therapy to help pass kidney stones, particularly those located in the lower part of the ureter (the tube connecting the kidney to the bladder)[4].

How Tamsulosin Works

Tamsulosin works by relaxing the muscles in the prostate and bladder neck. This action helps to improve urine flow and reduce symptoms of BPH. Specifically, it blocks alpha-1 receptors in these muscles, which leads to their relaxation[1]. By doing so, Tamsulosin can help alleviate symptoms such as:

  • Difficulty starting urination
  • Weak urine stream
  • Frequent need to urinate, especially at night
  • Feeling that the bladder is not completely empty after urination

Dosage Forms and Strengths

Tamsulosin is typically available in the following forms and strengths:

  • Oral capsules: 0.4 mg is the most common strength[2]
  • Modified-release (MR) capsules: These are designed to release the medication slowly over time[5]
  • In some countries, a 0.2 mg strength may also be available[1]

The dosage is typically once daily, often recommended to be taken 30 minutes after the same meal each day[5].

Clinical Studies and Effectiveness

Several clinical studies have been conducted to evaluate the effectiveness of Tamsulosin:

  • BPH Symptom Improvement: Studies have shown that Tamsulosin can significantly improve urinary symptoms associated with BPH, as measured by the International Prostate Symptom Score (IPSS)[1].
  • Urinary Retention Prevention: Research has investigated the use of Tamsulosin to prevent post-operative urinary retention in men undergoing certain surgeries[3].
  • Kidney Stone Passage: Some studies have explored the effectiveness of Tamsulosin in helping patients pass kidney stones more easily[4].
  • Combination Therapy: Research has also looked into combining Tamsulosin with other medications, such as mirabegron, for treating overactive bladder symptoms in men with BPH[6].

Potential Side Effects

While Tamsulosin is generally well-tolerated, it can cause some side effects. Common side effects may include:

  • Dizziness or lightheadedness, especially when standing up
  • Headache
  • Runny or stuffy nose
  • Abnormal ejaculation
  • Weakness

More serious side effects, though rare, can include severe dizziness, fainting, or allergic reactions. It’s important to report any unusual or severe side effects to your healthcare provider[2].

Precautions and Considerations

When taking Tamsulosin, keep in mind the following:

  • Drug Interactions: Tamsulosin may interact with other medications, particularly other alpha-blockers or drugs for erectile dysfunction. Always inform your doctor about all medications you’re taking[6].
  • Orthostatic Hypotension: This medication can cause a sudden drop in blood pressure when standing up, which may lead to dizziness or fainting. Take care when rising from a sitting or lying position[6].
  • Eye Surgery: If you’re planning to have cataract or glaucoma surgery, make sure your eye surgeon knows you’re taking Tamsulosin, as it can affect pupil dilation during surgery.
  • Prostate Cancer: BPH and prostate cancer can have similar symptoms. Tamsulosin treats BPH but does not prevent or treat prostate cancer. Regular prostate exams are still important.

Always follow your doctor’s instructions and don’t hesitate to ask questions about your treatment with Tamsulosin Hydrochloride.

Aspect Details
Drug Name Tamsulosin Hydrochloride (Brand names: Flomax, Harnal-D)
Primary Condition Treated Benign Prostatic Hyperplasia (BPH) with Lower Urinary Tract Symptoms (LUTS)
Dosages Studied 0.2 mg and 0.4 mg capsules
Primary Outcome Measures Changes in International Prostate Symptom Score (IPSS), voiding score, quality of life, Qmax, and post-void residual volume
Secondary Outcomes Time to acute urinary retention, BPH-related surgery
Bioequivalence Measures Area under the curve (AUC), maximum concentration (Cmax), time to maximum concentration (Tmax)
Safety Assessments Adverse events, vital signs, laboratory values, ECG changes
Study Designs Randomized, double-blind, parallel, comparative, crossover studies
Study Populations BPH patients with LUTS, healthy male subjects

FAQ

  • What is Tamsulosin Hydrochloride used for? Tamsulosin Hydrochloride is primarily used to treat Benign Prostatic Hyperplasia (BPH), a condition where the prostate gland becomes enlarged, causing lower urinary tract symptoms (LUTS).
  • What dosages of Tamsulosin Hydrochloride were studied in the clinical trials? The clinical trials studied various dosages of Tamsulosin Hydrochloride, including 0.2 mg and 0.4 mg capsules. Some trials compared these different dosages to assess their efficacy and safety.
  • How was the effectiveness of Tamsulosin Hydrochloride measured in these trials? The effectiveness was primarily measured using the International Prostate Symptom Score (IPSS), which assesses changes in urinary symptoms. Other measures included changes in voiding score, quality of life, maximum urinary flow rate (Qmax), and post-void residual volume (PVR).
  • Were there any side effects observed in the Tamsulosin Hydrochloride trials? While specific side effects weren't detailed in the provided trial information, the studies did monitor for adverse events, changes in vital signs, laboratory values, and ECG readings to assess the safety profile of Tamsulosin Hydrochloride.
  • What is bioequivalence and why was it studied in these trials? Bioequivalence refers to the comparison of different formulations or batches of a drug to ensure they have the same biological effects. Several trials studied bioequivalence to ensure that different formulations or manufacturing processes of Tamsulosin Hydrochloride produced equivalent results in the body.

Ongoing Clinical Trials on Tamsulosin Hydrochloride

  • Study on How Degarelix and Drug Combination Affect Gut Health in Patients with Prostate Cancer or Benign Prostate Hyperplasia

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland

  • Evaluation of tamsulosin and furosemide combination therapy after shock wave lithotripsy in patients with kidney stones

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Safety and Effectiveness of Oxitriptan and Tamsulosin Hydrochloride for Patients with Benign Prostatic Hyperplasia

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Portugal

  • Study of tamsulosin and furosemide combination therapy for patients after shock wave lithotripsy of kidney stones

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effectiveness of Tamsulosin for Treating Urinary Symptoms in Women with Multiple Sclerosis

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France

Glossary

  • Benign Prostatic Hyperplasia (BPH): A condition where the prostate gland becomes enlarged, often causing lower urinary tract symptoms in older men.
  • Lower Urinary Tract Symptoms (LUTS): A group of urinary symptoms that can include difficulty starting urination, weak urine stream, frequent urination, and feeling of incomplete bladder emptying.
  • International Prostate Symptom Score (IPSS): A questionnaire used to assess the severity of lower urinary tract symptoms associated with benign prostatic hyperplasia.
  • Qmax: The maximum urinary flow rate, which is a measure of how quickly urine flows during urination.
  • Post-void Residual Volume (PVR): The amount of urine left in the bladder after urination, which can be an indicator of how well the bladder is emptying.
  • Bioequivalence: The property of different drug formulations having the same biological effect in the body.
  • Area Under the Curve (AUC): A measure of the total exposure to a drug over time, used to assess bioequivalence and drug absorption.
  • Maximum Concentration (Cmax): The highest concentration of a drug in the blood after administration, used to assess the rate of drug absorption.
  • Elimination Half-life: The time it takes for half of a drug to be eliminated from the body, which helps determine dosing frequency.

References

  1. https://clinicaltrials.gov/study/NCT02303769
  2. https://clinicaltrials.gov/study/NCT02266511
  3. https://clinicaltrials.gov/study/NCT04491526
  4. https://clinicaltrials.gov/study/NCT05790902
  5. https://clinicaltrials.gov/study/NCT02417844
  6. https://clinicaltrials.gov/study/NCT02279615